GeneTune
01 / The story
Retatrutide has been studied for activity at GLP-1, GIP and glucagon receptors. That three-part design is the core of the original GeneTune visual comparison.
02 / In plain language
01
GLP-1
One incretin route involved in appetite and glucose regulation.
02
GIP
A second incretin route in the metabolic model.
03
Glucagon
A third receptor target that changes the research question.
THE IDEA TO KEEPThree targets describe the design; they do not guarantee an outcome.
03 / Where the evidence stops
Human trial · Phase 2 publication
A published randomized Phase 2 obesity trial evaluated retatrutide. These selected original frames explain the receptor model; trial results and safety require their own careful reading.